JEAN MACENAT: Open Payments
NPI 1104886860 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 62 payments from 15 companies in 2025. Trend: 2023 $1,502 · 2024 $1,232 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $200 |
| Ardelyx, Inc. | 8 | $171 |
| Merck Sharp & Dohme LLC | 8 | $163 |
| Gilead Sciences, Inc. | 1 | $119 |
| Amgen Inc. | 5 | $107 |
| Aimmune Therapeutics, Inc. | 5 | $105 |
| Novo Nordisk Inc | 5 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| PFIZER INC. | 2 | $43 |
Products named: IBSRELA, VERQUVO, Livdelzi, ZENPEP, OTEZLA, CREON, Kerendia, UBRELVY.
Industry payments across NY — which companies pay providers there.
